| REVIEW ARTICLE |
|
| Year : 2019 | Volume
: 5
| Issue : 2 | Page : 85-88 |
|
|
Shorter drug regimen of multidrug-resistant tuberculosis and the ambiguity in the World Health Organization recommendations
Rabbanie Tariq Wani1, Rehana Kausar2
1 Department of Community Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India
2 Directorate of Health Services, Srinagar, Jammu and Kashmir, India
Correspondence Address:
Rabbanie Tariq Wani
H# 39, Lane 3rd, Ibrahim Colony, Hyderpora, Srinagar, Jammu and Kashmir
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jcrsm.jcrsm_12_19
|
|
|
Organizations all over world are trying to shift towards making healthcare intervention more acceptable to the consumers at large, but any intervention made has its costeffective and costbeneficial implications which should be taken into consideration while incorporating changes. A recent change of switching to shorter regimen for multidrugresistant tuberculosis (MDRTB) can be a landmark step in the treatment of the disease but it has its own limitations which need to be addressed.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
